Updated Jul 16, 2026
Oltmans Curtis Gale is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $45K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-17 | FULC | Fulcrum Therapeutics, Inc. | S — Open-market sale [10b5-1] | 3.5K | $12.92 | $45K |
Oltmans Curtis Gale is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($45K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Oltmans Curtis Gale profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.